Azelaic acid
Azelaic acid is a lipid of Fatty Acyls (FA) class. Azelaic acid is associated with abnormalities such as Bacterial Infections and Infection. The involved functions are known as Anabolism, Signal Transduction, Plant Immunity, Signal and Signal Transduction Pathways. Azelaic acid often locates in Body tissue. The associated genes with Azelaic acid are AZI1 gene, FKBPL gene and MLL gene. The related lipids are sebacic acid.
Cross Reference
Introduction
To understand associated biological information of Azelaic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azelaic acid?
Azelaic acid is suspected in Infection, Bacterial Infections and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azelaic acid
PubChem Associated disorders and diseases
What pathways are associated with Azelaic acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Azelaic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azelaic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azelaic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azelaic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azelaic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azelaic acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Azelaic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| [Azelaic Acid--a new application in acne therapy. Expert's exchange. Berlin, 18-20 January 1991]. | 1991 | Hautarzt | pmid:1674505 | |
| Sobottka A and Lehmann P | [Rosacea 2009 : new advances in pathophysiology, clinical staging and therapeutic strategies]. | 2009 | Hautarzt | pmid:19957073 |
| Landthaler M et al. | [Lentigo of the glans penis]. | 1989 | Hautarzt | pmid:2732050 |
| Geier G et al. | [Effect of azelaic acid on the growth of melanoma cell cultures in comparison with fibroblast cultures]. | 1986 | Hautarzt | pmid:3700102 |
| Schöfer H | [Topical therapy of rosacea]. | 2013 | Hautarzt | pmid:23780475 |
| Schauber J | [Antimicrobial peptides, Vitamin D₃ and more. How rosacea may develop]. | 2011 | Hautarzt | pmid:22002717 |
| [Advances in pigment studies]. | 1983 | Hautarzt | pmid:6678891 | |
| Sand M et al. | Cutaneous lesions of the nose. | 2010 | Head Face Med | pmid:20525327 |
| New rosacea drug gets the red out. | 2004 | Health News | pmid:15002371 | |
| Jorand JP et al. | The "survival hormones": azelaic and pimelic acids, suppress the stress elicited by isolation conditions on the steroids and phospholipids of adult worker honeybees. | 1989 | Horm. Metab. Res. | pmid:2807145 |
| Usatine RP et al. | Acne vulgaris: a treatment update. | 1998 | Hosp Pract (1995) | pmid:9484299 |
| Panyosak A et al. | Safety assessment of azelaic acid and its derivatives entrapped in nanovesicles. | 2009 | Hum Exp Toxicol | pmid:19755450 |
| Ghosh S | Chemical leukoderma: what's new on etiopathological and clinical aspects? | 2010 Jul-Sep | Indian J Dermatol | pmid:21063518 |
| Safoury OS et al. | A study comparing chemical peeling using modified Jessner's solution and 15% trichloroacetic Acid versus 15% trichloroacetic acid in the treatment of melasma. | 2009 | Indian J Dermatol | pmid:20049268 |
| Rathi SK | Acne vulgaris treatment : the current scenario. | 2011 | Indian J Dermatol | pmid:21572783 |
| Bandyopadhyay D | Topical treatment of melasma. | 2009 | Indian J Dermatol | pmid:20101327 |
| Sarkar R et al. | Newer and upcoming therapies for melasma. | 2012 Jul-Aug | Indian J Dermatol Venereol Leprol | pmid:22772611 |
| Iraji F et al. | Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris. | 2007 Mar-Apr | Indian J Dermatol Venereol Leprol | pmid:17456913 |
| Khanna N and Rasool S | Facial melanoses: Indian perspective. | 2011 Sep-Oct | Indian J Dermatol Venereol Leprol | pmid:21860153 |
| Smit N et al. | The hunt for natural skin whitening agents. | 2009 | Int J Mol Sci | pmid:20054473 |
| Ebanks JP et al. | Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. | 2009 | Int J Mol Sci | pmid:19865532 |
| Karavelidis V et al. | Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior. | 2011 | Int J Nanomedicine | pmid:22162659 |
| Li N et al. | Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid. | 2010 | Int J Pharm | pmid:20025951 |
| Manosroi J et al. | Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-beta-cyclodextrin. | 2005 | Int J Pharm | pmid:15778061 |
| Vereecken P and Heenen M | Recurrent lentigo maligna melanoma: regression associated with local azelaic acid 20%. | 2002 Jan-Feb | Int. J. Clin. Pract. | pmid:11831841 |
| Gupta AK and Gover MD | Azelaic acid (15% gel) in the treatment of acne rosacea. | 2007 | Int. J. Dermatol. | pmid:17472690 |
| Baliña LM and Graupe K | The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. | 1991 | Int. J. Dermatol. | pmid:1816137 |
| Nguyen QH and Bui TP | Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. | 1995 | Int. J. Dermatol. | pmid:7737781 |
| RodrÃguez Prieto MA et al. | Treatment of lentigo maligna with azelaic acid. | 1993 | Int. J. Dermatol. | pmid:8505164 |
| Le Lay C et al. | Identification and quantification of antifungal compounds produced by lactic acid bacteria and propionibacteria. | 2016 | Int. J. Food Microbiol. | pmid:27350657 |
| Breathnach AS et al. | Effect of dicarboxylic acids (C6 and C9) on human choroidal melanoma in cell culture. | 1989 | Invest. Ophthalmol. Vis. Sci. | pmid:2925320 |
| Karimi AA et al. | Improvement of tissue survival of skin flaps by 5α-reductase inhibitors: possible involvement of nitric oxide and inducible nitric oxide synthase. | 2015 | Iran. Biomed. J. | pmid:25864816 |
| Verma P and Pathak K | Therapeutic and cosmeceutical potential of ethosomes: An overview. | 2010 | J Adv Pharm Technol Res | pmid:22247858 |
| Chudasama A et al. | Investigation of microemulsion system for transdermal delivery of itraconazole. | 2011 | J Adv Pharm Technol Res | pmid:22171289 |
| Maes M et al. | Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. | 2013 | J Affect Disord | pmid:22898471 |
| Salimon J et al. | Synthesis and physical properties of estolide ester using saturated Fatty Acid and ricinoleic Acid. | 2011 | J Autom Methods Manag Chem | pmid:22007150 |
| Jones DA | Rosacea, reactive oxygen species, and azelaic Acid. | 2009 | J Clin Aesthet Dermatol | pmid:20967185 |
| McFalda WL and Roebuck HL | Rational management of papulopustular rosacea with concomitant facial seborrheic dermatitis: a case report. | 2011 | J Clin Aesthet Dermatol | pmid:21278898 |
| Del Rosso JQ | The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. | 2009 | J Clin Aesthet Dermatol | pmid:20729951 |
| Davis EC and Callender VD | Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. | 2010 | J Clin Aesthet Dermatol | pmid:20725554 |
| Arizaga GG et al. | Chemical modification of zinc hydroxide nitrate and Zn-Al-layered double hydroxide with dicarboxylic acids. | 2008 | J Colloid Interface Sci | pmid:18243238 |
| Draelos ZD et al. | An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients. | 2006 | J Cosmet Dermatol | pmid:17173568 |
| Farshi S | Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma. | 2011 | J Cosmet Dermatol | pmid:22151936 |
| Lee GS | Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report. | 2008 | J Cosmet Laser Ther | pmid:18830869 |
| Esposito E et al. | Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. | 2004 May-Jun | J Cosmet Sci | pmid:15264053 |
| Patwardhan N | Conference Report: ACSICON 2008. | 2009 | J Cutan Aesthet Surg | pmid:20300376 |
| Asai Y et al. | Canadian Clinical Practice Guidelines for Rosacea. | 2016 | J Cutan Med Surg | pmid:27207355 |
| Choi YS et al. | A study of the efficacy of cleansers for acne vulgaris. | 2010 | J Dermatolog Treat | pmid:20394494 |
| Pazoki-Toroudi H et al. | Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. | 2010 | J Dermatolog Treat | pmid:20394495 |
| Manosroi A et al. | Characteristics and anti-proliferative activity of azelaic acid and its derivatives entrapped in bilayer vesicles in cancer cell lines. | 2007 | J Drug Target | pmid:17541842 |
| Iraji F et al. | Efficacy of 15% azelaic acid in psoriasis vulgaris: a randomized, controlled clinical trial. | 2010 | J Drugs Dermatol | pmid:20684146 |
| Kircik LH | Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. | 2011 | J Drugs Dermatol | pmid:21637899 |
| Wheeland RG and Dhawan S | Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system. | 2011 | J Drugs Dermatol | pmid:21637900 |
| Que SK and Bergstrom KG | Hyperpigmentation: old problem, new therapies. | 2009 | J Drugs Dermatol | pmid:19746682 |
| Thiboutot DM et al. | A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. | 2009 | J Drugs Dermatol | pmid:19588640 |
| Del Rosso JQ et al. | Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea. | 2010 | J Drugs Dermatol | pmid:20645521 |
| Conde JF et al. | Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. | 2007 | J Drugs Dermatol | pmid:17679183 |
| Thiboutot D | Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. | 2008 | J Drugs Dermatol | pmid:18246693 |
| Ziel K et al. | Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. | 2005 Nov-Dec | J Drugs Dermatol | pmid:16302558 |
| Nally JB and Berson DS | Topical therapies for rosacea. | 2006 | J Drugs Dermatol | pmid:16468288 |
| Fleischer A and Suephy C | The face and mind evaluation study: an examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life. | 2005 Sep-Oct | J Drugs Dermatol | pmid:16167417 |
| Thiboutot DM et al. | Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea. | 2008 | J Drugs Dermatol | pmid:18561584 |
| Bhatia ND and Del Rosso JQ | Optimal management of papulopustular rosacea: rationale for combination therapy. | 2012 | J Drugs Dermatol | pmid:22777226 |
| Del Rosso JQ and Kircik LH | Update on the management of rosacea: a status report on the current role and new horizons with topical azelaic acid. | 2014 | J Drugs Dermatol | pmid:25607798 |
| Woolery-Lloyd HC et al. | Retinoids and azelaic acid to treat acne and hyperpigmentation in skin of color. | 2013 | J Drugs Dermatol | pmid:23652891 |
| Jackson JM et al. | Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea. | 2013 | J Drugs Dermatol | pmid:23545911 |
| Shalita AR et al. | Inflammatory acne management with a novel prescription dietary supplement. | 2012 | J Drugs Dermatol | pmid:23377512 |
| Fluhr JW and Degitz K | [Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy]. | 2010 | J Dtsch Dermatol Ges | pmid:20482689 |
| Gollnick HP et al. | [Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies]. | 2004 | J Dtsch Dermatol Ges | pmid:16281587 |
| Worret WI and Fluhr JW | [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid]. | 2006 | J Dtsch Dermatol Ges | pmid:16638058 |
| Shemer A et al. | Azelaic acid (20%) cream in the treatment of acne vulgaris. | 2002 | J Eur Acad Dermatol Venereol | pmid:12046832 |
| Korting HC and Schöllmann C | Current topical and systemic approaches to treatment of rosacea. | 2009 | J Eur Acad Dermatol Venereol | pmid:19508315 |
| Elewski BE et al. | Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. | 2011 | J Eur Acad Dermatol Venereol | pmid:20586834 |
| Stinco G et al. | Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne. | 2007 | J Eur Acad Dermatol Venereol | pmid:17309452 |
| Mostafa FF et al. | Comparative study of some treatment modalities of rosacea. | 2009 | J Eur Acad Dermatol Venereol | pmid:18705632 |
| Kanitakis J | Linea fusca in a male adolescent successfully treated with azelaic acid. | 2008 | J Eur Acad Dermatol Venereol | pmid:18331308 |
| Gollnick H and Schramm M | Topical therapy in acne. | 1998 | J Eur Acad Dermatol Venereol | pmid:9891903 |
| Liao DC | Management of acne. | 2003 | J Fam Pract | pmid:12540312 |
| May D et al. | Clinical inquiries. What is the most effective treatment for acne rosacea? | 2011 | J Fam Pract | pmid:21301648 |
| Alevizos A et al. | Acne treatments: consider these options--and issues. | 2007 | J Fam Pract | pmid:17475157 |
| Punsalan T and Usatine RP | Red facial rash with "granitos". | 2005 | J Fam Pract | pmid:16144591 |
| Stewart JJ | Application of the PM6 method to modeling the solid state. | 2008 | J Mol Model | pmid:18449579 |
| Fujitani K et al. | Preparation of polycarboxylic acids by oxidative cleavage with oxygen / Co-Mn-Br system. | 2009 | J Oleo Sci | pmid:19915320 |
| Maru U et al. | [In vitro diffusion and skin penetration of azelaic preparations: study of correlations]. | 1982 May-Jun | J Pharm Belg | pmid:7131228 |
| Hinz DC | Efficiency improvement for sulfated ash determination by usage of a microwave muffle furnace. | 2007 | J Pharm Biomed Anal | pmid:17280812 |
| Gatti R et al. | Analysis of aliphatic dicarboxylic acids in pharmaceuticals and cosmetics by liquid chromatography (HPLC) with fluorescence detection. | 1995 | J Pharm Biomed Anal | pmid:9696574 |
| Solo AJ and Gardner JO | Agents for alkylating steroid hormone receptors. 3. Omega-substituted esters of 17-alpha-hydroxyprogesterone. | 1971 | J Pharm Sci | pmid:5115254 |
| Liu C et al. | Heterogeneous reaction of suspended phosmet particles with NO3 radicals. | 2011 | J Phys Chem A | pmid:21870875 |
| Hung HM et al. | Products and mechanisms of the reaction of oleic acid with ozone and nitrate radical. | 2005 | J Phys Chem A | pmid:16833788 |
| Page MM et al. | Ion chromatographic analysis of amines, alkanolamines, and associated anions in concrete. | 2005 | J Sep Sci | pmid:15835735 |
| Alzweiri M et al. | Gas chromatography/trace analysis of derivatized azelaic acid as a stability marker. | 2013 | J Sep Sci | pmid:23893928 |
| Wu YH et al. | Effects of Chinese herbal medicine combined with He-Ne laser on lipoperoxide and superoxide dismutase in chloasma patients. | 2009 | J Tradit Chin Med | pmid:19894376 |
| Thiboutot D et al. | Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. | 2003 | J. Am. Acad. Dermatol. | pmid:12789172 |
| Webster G | Combination azelaic acid therapy for acne vulgaris. | 2000 | J. Am. Acad. Dermatol. | pmid:10898830 |
| Sheth VM and Pandya AG | Melasma: a comprehensive update: part II. | 2011 | J. Am. Acad. Dermatol. | pmid:21920242 |
| Elewski BE et al. | In reference to the October 2004 comprehensive overview of rosacea therapy. | 2007 | J. Am. Acad. Dermatol. | pmid:17870440 |
| Kameyama K et al. | Treatment of reticulate acropigmentation of Kitamura with azelaic acid. An immunohistochemical and electron microscopic study. | 1992 | J. Am. Acad. Dermatol. | pmid:1613143 |
| Gupta AK et al. | The treatment of melasma: a review of clinical trials. | 2006 | J. Am. Acad. Dermatol. | pmid:17097400 |
| Nazzaro-Porro M | Azelaic acid. | 1987 | J. Am. Acad. Dermatol. | pmid:2963038 |
| Maddin S | A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. | 1999 | J. Am. Acad. Dermatol. | pmid:10365928 |